Marcus Jamil
Papers
7
Total Citations
532
H-Index
7
About
Marcus Jamil is a leading urologic oncologist whose research focuses on refining surgical techniques for prostate and upper tract cancers, with a particular emphasis on robotic-assisted procedures. His landmark contributions include pioneering the Retzius-sparing approach during robot-assisted radical prostatectomy, a technique that dramatically improves early urinary continence recovery without compromising cancer control. This work, published in a 2017 randomized controlled trial (215 citations) and its one-year update (176 citations), has reshaped surgical practice for thousands of men worldwide. Beyond prostate cancer, Jamil leads the ROBUUST collaborative group, a multinational consortium advancing the evidence base for robotic nephroureterectomy in upper tract urothelial carcinoma. His multicenter analyses—including a 58-cited propensity-matched study and a 30-cited comparison of open, laparoscopic, and robotic approaches—demonstrate that robotic surgery offers superior perioperative outcomes while maintaining oncologic efficacy. He has also investigated the role of lymph node dissection and variant histology in these patients, contributing to more personalized surgical decision-making. Through these high-impact studies, Jamil has established himself as a key figure in the transition toward minimally invasive, function-preserving urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7